Oral hormone therapy for menopausal women was associated with an increased
risk of hospitalisation for depression, according to a study that combined
data from multiple Danish demographic and health registries.
According to the study’s authors, the risk was greatest in women 45 to 50
years old and in the first few years after beginning hormone therapy.
risk of hospitalisation for depression, according to a study that combined
data from multiple Danish demographic and health registries.
According to the study’s authors, the risk was greatest in women 45 to 50
years old and in the first few years after beginning hormone therapy.
